Skip to main navigation Skip to search Skip to main content

Impact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing: An Observational Retrospective Cohort

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalPrimary Care Companion for CNS Disorders
Volume17
DOIs
StatePublished - Mar 5 2015

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this